Concurrent Technologies Corporation (CTC) has once again been chosen for the prestigious Defense Security Service (DSS) James S. Cogswell Outstanding Industrial Security Achievement Award. CTC previously won the Cogswell Award in 2006.
|
||||||
Companies are judged on factors including establishing and maintaining a security program that far exceeds the basic National Industrial Security Program requirements and providing leadership to other cleared facilities in establishing best practices while maintaining the highest standards for security. Facilities are eligible only if they achieve a minimum of two consecutive “Superior” industrial security review ratings and show a sustained degree of excellence and innovation in their overall security program management, implementation, and oversight.
“Concurrent Technologies Corporation has always been dedicated to helping develop and protect the nation's most sensitive programs and capabilities; in fact, we’ve earned ‘Superior’ ratings on the past three DSS evaluations,” said Edward J. Sheehan, Jr., President and Chief Executive Officer, CTC. “Congratulations to our Enterprise Security team, program managers, analysts, technicians, engineers, administrators, and others, whose efforts have distinguished CTC in a significant way.”
Large and small facilities across the country are eligible for this award. All nominees go through a vigorous vetting process that includes external input and a national team review.
“Our employees’ unwavering commitment to protecting programs and information made this level of recognition possible,” said Ronald R. Newsom, CTC Security Manager. “From following facility access rules to properly handling classified materials and information systems, CTC employees consistently demonstrate an outstanding security culture, proving that CTC is an especially trustworthy government-industry partner.”
CLICK HERE for the full DSS press release.
Concurrent Technologies Corporation (CTC) is an independent, nonprofit, applied scientific research and development professional services organization. Together with our affiliates, Enterprise Ventures Corporation and CTC Foundation, we leverage research, development, test and evaluation work to provide transformative, full lifecycle solutions. To best serve our clients’ needs, we offer the complete ability to fully design, develop, test, prototype and build. We support our clients’ core mission objectives with customized solutions and strive to exceed expectations. For more information about CTC, visit www.ctc.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/baea8cce-59d7-45cf-8327-8e7e17d59b7f
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5e040916-5ee1-43bc-83d8-281cd946aaf4
Mary Bevan Concurrent Technologies Corporation 814-269-2490 [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Samsung Electronics Shares Jump on HBM4 Mass Production Report
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



